Travere Therapeutics Inc (TVTX)
R&D to Revenue
41.98%
Fiscal year · Period ending:
TVTX R&D to Revenue
Latest reported41.98%period ending
Latest reported41.98%period ending
TVTX FY R&D/Revenue (0.00% → 41.98%)
Latest values, visible window
High-resolution chart · PNG
TVTX r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 41.9807% | |
| 121.2398% | |
| 168.6817% | |
| 207.6859% | |
| 152.5828% | |
| 66.4443% | |
| 80.395% | |
| 75.3486% | |
| 50.4515% | |
| 53.0373% | |
| 50.4805% | |
| 169.4673% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |